BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-0.6%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.9B
AUM Growth
+$1.9B
Cap. Flow
+$26.4M
Cap. Flow %
1.39%
Top 10 Hldgs %
54.31%
Holding
63
New
4
Increased
4
Reduced
2
Closed
2

Top Buys

1
CLYM
Climb Bio, Inc. Common Stock
CLYM
$18.5M
2
ITOS icon
iTeos Therapeutics
ITOS
$17M
3
REPL icon
Replimune Group
REPL
$13.8M
4
CGEM icon
Cullinan Oncology
CGEM
$11.5M
5
SYRE icon
Spyre Therapeutics
SYRE
$10.5M

Top Sells

1
ATRA icon
Atara Biotherapeutics
ATRA
$33.9M
2
VKTX icon
Viking Therapeutics
VKTX
$24.6M
3
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$2.55M
4
DBVT
DBV Technologies
DBVT
$200K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BDTX icon
51
Black Diamond Therapeutics
BDTX
$157M
$2.36M 0.12%
506,000
– –
ABSI icon
52
Absci
ABSI
$357M
$2.16M 0.11%
700,000
– –
OBIO icon
53
Orchestra BioMed
OBIO
$147M
$1.94M 0.1%
238,193
– –
ZNTL icon
54
Zentalis Pharmaceuticals
ZNTL
$122M
$1.84M 0.1%
450,000
– –
TARA icon
55
Protara Therapeutics
TARA
$120M
$1.69M 0.09%
811,627
+602,400
+288% +$1.25M
ATRA icon
56
Atara Biotherapeutics
ATRA
$84.6M
$1.41M 0.07%
166,000
-3,984,000
-96% -$33.9M
BCAB icon
57
BioAtla
BCAB
$26.7M
$940K 0.05%
686,347
– –
MIST icon
58
Milestone Pharmaceuticals
MIST
$156M
$408K 0.02%
309,007
– –
DBVT
59
DBV Technologies
DBVT
$264M
$200K 0.01%
250,000
-250,000
-50% -$200K
NUVB.WS icon
60
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$68M
$42.7K ﹤0.01%
266,666
– –
SRZNW icon
61
Surrozen, Inc. Warrant
SRZNW
$71.6K
$1.11K ﹤0.01%
66,666
– –
LABD icon
62
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.5M
– –
-350,000
Closed -$2.55M
VKTX icon
63
Viking Therapeutics
VKTX
$3.04B
– –
-300,000
Closed -$24.6M
1 2
3